|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9646
|
|
pubmed:dateCreated |
2008-10-20
|
|
pubmed:abstractText |
The ORACLE I trial compared the use of erythromycin and/or amoxicillin-clavulanate (co-amoxiclav) with that of placebo for women with preterm rupture of the membranes without overt signs of clinical infection, by use of a factorial randomised design. The aim of the present study--the ORACLE Children Study I--was to determine the long-term effects on children of these interventions.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
11
|
|
pubmed:volume |
372
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1310-8
|
|
pubmed:dateRevised |
2009-8-20
|
|
pubmed:meshHeading |
pubmed-meshheading:18804274-Adult,
pubmed-meshheading:18804274-Amoxicillin-Potassium Clavulanate Combination,
pubmed-meshheading:18804274-Antibiotic Prophylaxis,
pubmed-meshheading:18804274-Child,
pubmed-meshheading:18804274-Child Mortality,
pubmed-meshheading:18804274-Child Welfare,
pubmed-meshheading:18804274-Educational Status,
pubmed-meshheading:18804274-England,
pubmed-meshheading:18804274-Erythromycin,
pubmed-meshheading:18804274-Female,
pubmed-meshheading:18804274-Fetal Membranes, Premature Rupture,
pubmed-meshheading:18804274-Follow-Up Studies,
pubmed-meshheading:18804274-Health Status,
pubmed-meshheading:18804274-Humans,
pubmed-meshheading:18804274-Logistic Models,
pubmed-meshheading:18804274-Male,
pubmed-meshheading:18804274-Pelvic Infection,
pubmed-meshheading:18804274-Pregnancy,
pubmed-meshheading:18804274-Pregnancy Complications, Infectious,
pubmed-meshheading:18804274-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial.
|
|
pubmed:affiliation |
Reproductive Sciences Section, Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK. oracle@leicester.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
